Back to StakeholdersPrimary Policy Link
Categories
1 domain / 2 areas / 1 specialization
Braeburn Inc.
Data updated
Biopharmaceutical company responsible for BRIXADI REMS implementation in the U.S., with certified provider and pharmacy requirements and controlled outpatient distribution pathways.
Regulation & Enforcement Snapshot
REMS AdministratorsAuthority Type
REMS Program Administrator
Jurisdiction
National
Coverage
1 country
Binding Strength
Programmatic Requirement
Function Areas
Risk Evaluation and Mitigation OversightData Reporting RequirementsCompliance Monitoring and Inspections
Framework / Program
BRIXADI REMS Program
Policy Notes
BRIXADI is distributed under a REMS framework with healthcare setting, prescriber, and pharmacy controls to reduce diversion and unsafe administration pathways.
Verification
Verified
Psychedelic Engagement
Psychedelic-Adjacent Focus
Framework Status
Active
Last Verified
Apr 8, 2026
Quick Facts
- Website
- Visit